Alexion Pharmaceuticals Mergers & Acquisitions Contracts & Agreements
9 Contracts & Agreements
- Merger Agreements (9 contracts)
- AGREEMENT AND PLAN OF MERGER dated as of December12, 2020 among ASTRAZENECA PLC, DELTA OMEGA SUB HOLDINGS INC., DELTA OMEGA SUB HOLDINGS INC. 1, DELTA OMEGA SUB HOLDINGS LLC 2 and... (Filed With SEC on December 14, 2020)
- Agreement and Plan of Merger, dated as of May 5, 2020, by and among Portola Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc. and Odyssey Merger Sub Inc (Filed With SEC on May 7, 2020)
- Agreement and Plan of Merger, dated October 15, 2019, by and among Alexion, Beagle Merger Sub, Inc. and Achillion (Filed With SEC on October 16, 2019)
- Agreement, dated as of September 7, 2018, by and between Alexion Pharma Holding Unlimited Company, Shareholder Representative Services LLC, Fonds de Solidarit des Travailleurs du... (Filed With SEC on October 24, 2018)
- Agreement and Plan of Merger, dated as of September 25, 2018, by and among Alexion Pharmaceuticals, Inc., Syracuse Merger Sub, Inc., Syntimmune, Inc. and Shareholder... (Filed With SEC on October 24, 2018)
- AGREEMENT AND PLAN OF REORGANIZATION by and among ALEXION PHARMACEUTICALS, INC., PULSAR MERGER SUB INC., GALAXY MERGER SUB LLC, and SYNAGEVA BIOPHARMA CORP. Dated as of May 5, 2015 (Filed With SEC on May 6, 2015)
- FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER (Filed With SEC on February 7, 2012)
- OMITTED INFORMATION IS THE SUBJECT OF A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 AND HAS BEEN FILED SEPARATELY WITH THE... (Filed With SEC on January 4, 2012)
- OMITTED INFORMATION IS THE SUBJECT OF A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 AND HAS BEEN FILED SEPARATELY WITH THE... (Filed With SEC on February 3, 2011)
